Loading clinical trials...
Loading clinical trials...
A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model
Conditions
Interventions
BRM421
Placebo
Locations
4
United States
Eye Research Foundation
Newport Beach, California, United States
Midwest Cornea Associates, LLC
Indianapolis, Indiana, United States
Andover Eye Associates
Andover, Massachusetts, United States
Total Eye Care
Memphis, Tennessee, United States
Start Date
January 15, 2020
Primary Completion Date
June 23, 2020
Completion Date
June 23, 2020
Last Updated
October 21, 2021
NCT07295691
NCT03135327
NCT06771427
NCT06220474
NCT06291194
NCT04685109
Lead Sponsor
BRIM Biotechnology Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions